ZA200004854B - Treatment of cardiac hypertrophy. - Google Patents

Treatment of cardiac hypertrophy.

Info

Publication number
ZA200004854B
ZA200004854B ZA200004854A ZA200004854A ZA200004854B ZA 200004854 B ZA200004854 B ZA 200004854B ZA 200004854 A ZA200004854 A ZA 200004854A ZA 200004854 A ZA200004854 A ZA 200004854A ZA 200004854 B ZA200004854 B ZA 200004854B
Authority
ZA
South Africa
Prior art keywords
treatment
cardiac hypertrophy
hypertrophy
cardiac
Prior art date
Application number
ZA200004854A
Other languages
English (en)
Inventor
Hongkui Jin
Hsienwie Lu
Nicholas J Paoni
Renhui Yang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA200004854B publication Critical patent/ZA200004854B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
ZA200004854A 1998-04-02 2000-09-13 Treatment of cardiac hypertrophy. ZA200004854B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8044898P 1998-04-02 1998-04-02

Publications (1)

Publication Number Publication Date
ZA200004854B true ZA200004854B (en) 2001-09-26

Family

ID=22157456

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200004854A ZA200004854B (en) 1998-04-02 2000-09-13 Treatment of cardiac hypertrophy.

Country Status (18)

Country Link
US (2) US6187304B1 (fr)
EP (2) EP1067958B1 (fr)
JP (2) JP5030329B2 (fr)
CN (1) CN1201814C (fr)
AR (1) AR018174A1 (fr)
AT (2) ATE410181T1 (fr)
AU (1) AU757910B2 (fr)
BR (1) BR9909422A (fr)
CA (1) CA2325442C (fr)
DE (2) DE69939723D1 (fr)
DK (2) DK1067958T3 (fr)
ES (2) ES2314786T3 (fr)
HK (2) HK1036019A1 (fr)
IL (1) IL138812A0 (fr)
NZ (1) NZ506854A (fr)
TW (1) TWI243682B (fr)
WO (1) WO1999051260A2 (fr)
ZA (1) ZA200004854B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192659A1 (en) * 1997-09-17 2002-12-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ES2314786T3 (es) * 1998-04-02 2009-03-16 Genentech, Inc. Uso de interferon gamma para el tratamiento de la hipertrofia cardiaca.
WO2001003720A2 (fr) * 1999-07-12 2001-01-18 Genentech, Inc. Stimulation ou inhibition de l'angiogenese et de la cardiovascularisation avec des homologues de ligands et de recepteurs du facteur de necrose tumorale
US7838225B2 (en) * 1999-10-29 2010-11-23 Hologic, Inc. Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase
US7625584B2 (en) * 2000-11-30 2009-12-01 The Research Foundation Of State University Of New York Method of complexing a protein by the use of a dispersed system and proteins thereof
US8110218B2 (en) * 2000-11-30 2012-02-07 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein-lipid complexes
WO2002089828A2 (fr) * 2001-05-04 2002-11-14 Institute Of Molecular And Cell Biology Traitement de l'ischemie
AU2002342163B2 (en) * 2001-11-06 2007-11-08 Laboratoires Serono Sa Methods of treating endometreosis
EP3578168A1 (fr) * 2002-02-14 2019-12-11 Chugai Seiyaku Kabushiki Kaisha Formulation de solutions contenant des anticorps comprenant un sucre comme stabilisant
US20050245509A1 (en) * 2002-08-29 2005-11-03 Santen Pharmacecutical Co., Ltd. Remedy for glaucoma comprising rho kinase inhibitor and prostaglandins
CA2506464C (fr) * 2002-11-18 2012-07-31 Santen Pharmaceutical Co., Ltd. Medicament contre le glaucome comprenant un inhibiteur de la rho-kinase et un .beta.-bloquant
EP1522857A1 (fr) * 2003-10-09 2005-04-13 Universiteit Maastricht Méthode pour identifier des individus qui risquent de développer une défaillance cardiaque par la détection du taux de galectine-3 ou thrombospondine-2
JP5866601B2 (ja) * 2008-06-18 2016-02-17 ザ テキサス エーアンドエム ユニバーシティ システムＴｈｅ Ｔｅｘａｓ Ａ＆Ｍ Ｕｎｉｖｅｒｓｉｔｙ Ｓｙｓｔｅｍ 医薬組成物の製造方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US5096705A (en) 1981-10-19 1992-03-17 Genentech, Inc. Human immune interferon
US5582824A (en) 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US4929544A (en) 1982-04-23 1990-05-29 Sri International Reagents, methods, and test kit for diagnosing/monitoring cancer in humans
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4944941A (en) 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
SE462364B (sv) 1988-09-30 1990-06-18 Goeran Hansson Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos
DK0502997T3 (da) 1989-12-01 1995-07-17 Childrens Medical Center Behandling af atopiske sygdomme med gamma-interferon
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5573762A (en) 1995-04-24 1996-11-12 Genentech, Inc. Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
DE69636112T2 (de) * 1995-08-30 2006-12-14 Toray Industries, Inc. Verfahren zum testen von myocarditis und cardiomyopathie
ES2314786T3 (es) * 1998-04-02 2009-03-16 Genentech, Inc. Uso de interferon gamma para el tratamiento de la hipertrofia cardiaca.

Also Published As

Publication number Publication date
ATE410181T1 (de) 2008-10-15
DE69939723D1 (de) 2008-11-20
EP1702623A3 (fr) 2007-01-10
EP1702623B1 (fr) 2008-10-08
DK1702623T3 (da) 2009-01-19
EP1702623A2 (fr) 2006-09-20
HK1099197A1 (en) 2007-08-10
BR9909422A (pt) 2001-09-11
NZ506854A (en) 2003-07-25
CA2325442C (fr) 2011-10-11
EP1067958B1 (fr) 2006-07-05
WO1999051260A2 (fr) 1999-10-14
AR018174A1 (es) 2001-10-31
IL138812A0 (en) 2001-10-31
DE69932235T2 (de) 2007-06-14
US6187304B1 (en) 2001-02-13
CN1201814C (zh) 2005-05-18
EP1067958A2 (fr) 2001-01-17
JP2002510645A (ja) 2002-04-09
WO1999051260A3 (fr) 1999-12-09
DE69932235D1 (de) 2006-08-17
CA2325442A1 (fr) 1999-10-14
US6989364B1 (en) 2006-01-24
ATE332144T1 (de) 2006-07-15
ES2314786T3 (es) 2009-03-16
HK1036019A1 (en) 2001-12-21
ES2267258T3 (es) 2007-03-01
AU757910B2 (en) 2003-03-13
JP2009256375A (ja) 2009-11-05
CN1300221A (zh) 2001-06-20
TWI243682B (en) 2005-11-21
AU3102499A (en) 1999-10-25
JP5030329B2 (ja) 2012-09-19
DK1067958T3 (da) 2006-11-06

Similar Documents

Publication Publication Date Title
AU2001249881A1 (en) Method of treating the heart
GB9824436D0 (en) Methods of treatment
ZA200108446B (en) Novel method of treatment.
HK1099197A1 (en) Use of interferon gamma for the treatment of cardiac hypertrophy
ZA991220B (en) Method of treating heart failure.
GB9800942D0 (en) Well treatment
ZA986363B (en) Novel method of treatment.
ZA97986B (en) Treatment of liquors.
ZA985237B (en) Novel method of treatment.
AU8451298A (en) Treatment of fabrics
GB2339576B (en) Biomass treatment
ZA986364B (en) Novel method of treatment.
ZA986365B (en) Novel method of treatment.
GB2333522B (en) Water treatment
ZA99253B (en) Treatment of waxes.
ZA973380B (en) Treatment of washwater.
ZA200109120B (en) Use of Arylalkanoylpyridazines.
ZA200007396B (en) Method of treatment.
AP2005003432A0 (en) Novel method of treatment.
AU6088099A (en) Water treatment
ZA994585B (en) Treatment of water.
GB9818524D0 (en) Inorgasmia treatment
GB9815497D0 (en) Treatment
ZA996625B (en) Treatment of congestive heart failure.
ZA996546B (en) Treatment of water.